FTSE 100

FTSE 100 Market news covers the latest developments for the FTSE 100 Index, which tracks the 100 most highly capitalised blue‑chip companies listed on the London Stock Exchange.

This category includes updates on company admissions and delistings, quarterly and annual results, mergers and acquisitions, board appointments and departures, regulatory news and policy changes.

Compass Group reports continued strong quarterly revenue growth

Compass Group reported 7.1% organic revenue growth in the third quarter and said it remains on track for another year of strong earnings growth...

GSK filing accepted by EMA for Bexsero booster label update

GSK says the EMA has accepted a submission to update Bexsero’s label to include a single-dose booster for older previously vaccinated individuals...

Experian reports 7% organic revenue growth in first quarter

Experian reported first-quarter revenue growth of 10% at actual exchange rates and said full-year expectations remain unchanged...

DCC reports year-on-year growth in first quarter

DCC said first-quarter trading was ahead of the prior year, with outlook, development activity and a proposed name change also outlined...

Convatec names NED and outlines CFO transition

Convatec has outlined finance leadership changes, appointed Tobias Hestler as a Non-Executive Director and reaffirmed its 2026 expectations...

Rio Tinto maintains 2026 guidance as iron ore sales and lithium output rise

Rio Tinto reported higher first-half copper equivalent production, with stronger copper and lithium output and unchanged full-year guidance...

Barratt Redrow reports FY26 trading update and launches £386m buyback

Barratt Redrow has reported FY26 trading performance in line with expectations and announced a new share buyback programme...

BP expects stronger Q2 2026 margins as net debt falls

Bp Plc has provided a second quarter 2026 trading statement, outlining expected production, refining and net debt movements...

Taylor Wimpey appoints Sarah Warby as independent non-executive director

Taylor Wimpey has appointed Sarah Warby as an independent non-executive director and confirmed further board changes...

Astrazeneca secures global rights to Zegfrovy in EGFR-mutated lung cancer

Astrazeneca Plc has agreed an exclusive licence with Dizal Pharmaceutical for Zegfrovy, adding a novel oral EGFR inhibitor to its oncology portfolio...

GSK reports positive interim AZUR-1 results for Jemperli in rectal cancer

GSK has reported positive interim AZUR-1 results for Jemperli in dMMR/MSI-H locally advanced rectal cancer, with the study meeting its primary objective...

Polar Capital Technology Trust NAV doubles as assets reach £7.3bn

Polar Capital Technology Trust has reported full-year figures showing higher net assets, NAV per share and share price for the year ended 30 April.....

LondonMetric reports strong portfolio performance ahead of AGM

LondonMetric Property Plc reports £139 million of investment transactions since 1 April 2026, alongside higher rental income and improved occupancy...

Severn Trent reports strong trading progress and higher capital investment in FY27

Severn Trent says performance is in line with expectations, with higher capital investment and refinancing completed in June...

Informa appoints Tom Glocer as Chair-Elect

Informa has appointed Tom Glocer as chair-elect, with a managed transition to non-executive chair planned for 2027...

Centrica confirms Sizewell B life extension deal to 2055

Centrica has confirmed a 20-year regulated Contract for Difference framework for Sizewell B, supporting extended operations to 2055...

AstraZeneca and Ionis’ Wainua misses Phase III ATTR-CM trial endpoint

The CARDIO-TTRansform Phase III trial1 for AstraZeneca and Ionis' Wainua (eplontersen) in patients with transthyretin-mediated amyloid cardiomyopathy (ATTR-CM) did not meet the primary efficacy.....

Unite Group reiterates FY2026 earnings guidance as student reservations rise

Unite Group reports stronger reservations, confirms disposal progress, and details Q2 valuation movements across USAF and LSAV...

Halma expands healthcare portfolio with Dreampath acquisition

Halma has announced the acquisition of Dreampath, adding tissue sample traceability and storage capabilities to its Healthcare Sector...

Coca-Cola HBC to showcase Egypt business in Bitesize Investor event

Coca-Cola HBC is hosting the latest Bitesize Investor series event in Cairo, focusing on its Egypt business and long-term growth opportunities...
Search

Funds

FTSE 100

Compass Group reports continued strong quarterly revenue growth

Compass Group reported 7.1% organic revenue growth in the third quarter and said it remains on track for another year of strong earnings growth...

GSK filing accepted by EMA for Bexsero booster label update

GSK says the EMA has accepted a submission to update Bexsero’s label to include a single-dose booster for older previously vaccinated individuals...

Experian reports 7% organic revenue growth in first quarter

Experian reported first-quarter revenue growth of 10% at actual exchange rates and said full-year expectations remain unchanged...

DCC reports year-on-year growth in first quarter

DCC said first-quarter trading was ahead of the prior year, with outlook, development activity and a proposed name change also outlined...

Convatec names NED and outlines CFO transition

Convatec has outlined finance leadership changes, appointed Tobias Hestler as a Non-Executive Director and reaffirmed its 2026 expectations...

Rio Tinto maintains 2026 guidance as iron ore sales and lithium output rise

Rio Tinto reported higher first-half copper equivalent production, with stronger copper and lithium output and unchanged full-year guidance...

Barratt Redrow reports FY26 trading update and launches £386m buyback

Barratt Redrow has reported FY26 trading performance in line with expectations and announced a new share buyback programme...

BP expects stronger Q2 2026 margins as net debt falls

Bp Plc has provided a second quarter 2026 trading statement, outlining expected production, refining and net debt movements...

Taylor Wimpey appoints Sarah Warby as independent non-executive director

Taylor Wimpey has appointed Sarah Warby as an independent non-executive director and confirmed further board changes...

Astrazeneca secures global rights to Zegfrovy in EGFR-mutated lung cancer

Astrazeneca Plc has agreed an exclusive licence with Dizal Pharmaceutical for Zegfrovy, adding a novel oral EGFR inhibitor to its oncology portfolio...

GSK reports positive interim AZUR-1 results for Jemperli in rectal cancer

GSK has reported positive interim AZUR-1 results for Jemperli in dMMR/MSI-H locally advanced rectal cancer, with the study meeting its primary objective...

Polar Capital Technology Trust NAV doubles as assets reach £7.3bn

Polar Capital Technology Trust has reported full-year figures showing higher net assets, NAV per share and share price for the year ended 30 April.....

LondonMetric reports strong portfolio performance ahead of AGM

LondonMetric Property Plc reports £139 million of investment transactions since 1 April 2026, alongside higher rental income and improved occupancy...

Severn Trent reports strong trading progress and higher capital investment in FY27

Severn Trent says performance is in line with expectations, with higher capital investment and refinancing completed in June...

Informa appoints Tom Glocer as Chair-Elect

Informa has appointed Tom Glocer as chair-elect, with a managed transition to non-executive chair planned for 2027...

Centrica confirms Sizewell B life extension deal to 2055

Centrica has confirmed a 20-year regulated Contract for Difference framework for Sizewell B, supporting extended operations to 2055...

AstraZeneca and Ionis’ Wainua misses Phase III ATTR-CM trial endpoint

The CARDIO-TTRansform Phase III trial1 for AstraZeneca and Ionis' Wainua (eplontersen) in patients with transthyretin-mediated amyloid cardiomyopathy (ATTR-CM) did not meet the primary efficacy.....

Unite Group reiterates FY2026 earnings guidance as student reservations rise

Unite Group reports stronger reservations, confirms disposal progress, and details Q2 valuation movements across USAF and LSAV...

Halma expands healthcare portfolio with Dreampath acquisition

Halma has announced the acquisition of Dreampath, adding tissue sample traceability and storage capabilities to its Healthcare Sector...

Coca-Cola HBC to showcase Egypt business in Bitesize Investor event

Coca-Cola HBC is hosting the latest Bitesize Investor series event in Cairo, focusing on its Egypt business and long-term growth opportunities...
Search

Funds

FTSE 100

FTSE 100

Funds